It looks like this podcast has ended some time ago. This means that no new episodes have been added some time ago. If you're the host of this podcast, you can check whether your RSS file is reachable for podcast clients.
Medicine Matters oncology
by Springer HealthcareInterviews with clinical experts, discussing key issues in oncology.
Copyright: Springer Healthcare, part of the Springer Nature group
Episodes
ALL and infection: Unpicking the connection (with Mel Greaves)
10m · PublishedProfessor Mel Greaves (Institute of Cancer Research, London, UK) discusses his proposed theory for the etiology of childhood acute lymphoblastic leukemia, in which early microbial exposure plays a key role. He outlines the evidence supporting the hypothesis and delves into the implications.
Find more on Medicine Matters oncology
This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on October 15, 2018.
SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan)
10m · PublishedAdvisory Board member and study author Paul Nathan, from the Mount Vernon Cancer Centre in Middlesex, UK, discusses the phase III SUMIT trial, which evaluated the addition of the MEK inhibitor selumetinib to dacarbazine in patients with metastatic uveal melanoma.
Find more on Medicine Matters oncology
This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on May 4, 2018.
Expert comment: AMPLE trial (with Fabien Maldonado)
13m · PublishedIn this podcast, Fabien Maldonado, from Vanderbilt University Medical Center in Nashville, Tennessee, USA, provides an independent comment on the AMPLE trial, published in JAMA, which aimed to establish the more effective technique for reducing the number of hospitalization days in patients with malignant pleural effusion.
Find more on Medicine Matters oncology
This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on January 2, 2018.
Bevacizumab in cervical cancer (with Krishnansu Tewari)
9m · PublishedThe phase III GOG 240 trial evaluated bevacizumab in women with advanced cervical cancer - Advisory Board member and lead investigator Krishnansu Tewari outlines the results of the final analysis in this podcast.
Find more on Medicine Matters oncology
This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on December 12, 2017.
Medicine Matters oncology has 14 episodes in total of non- explicit content. Total playtime is 2:39:00. The language of the podcast is English. This podcast has been added on December 24th 2022. It might contain more episodes than the ones shown here. It was last updated on March 24th, 2024 02:20.
